Equitable Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$674K Buy
3,188
+823
+35% +$177K 0.03% 278
2025
Q4
$486K Sell
2,365
-523
-18% -$98.4K 0.02% 319
2025
Q3
$453K Hold
2,888
0.02% 330
2025
Q2
$485K Buy
2,888
+76
+3% +$11.3K 0.02% 312
2025
Q1
$387K Sell
2,812
-823
-23% -$105K 0.02% 358
2024
Q4
$430K Hold
3,635
0.02% 348
2024
Q3
$402K Sell
3,635
-336
-8% -$35.1K 0.03% 351
2024
Q2
$390K Hold
3,971
0.03% 341
2024
Q1
$444K Sell
3,971
-235
-6% -$25.4K 0.03% 317
2023
Q4
$424K Buy
4,206
+277
+7% +$27.5K 0.03% 303
2023
Q3
$341K Sell
3,929
-992
-20% -$89.7K 0.03% 320
2023
Q2
$465K Sell
4,921
-1,546
-24% -$131K 0.04% 271
2023
Q1
$488K Buy
6,467
+2,286
+55% +$172K 0.04% 256
2022
Q4
$321K Buy
4,181
+772
+23% +$58.7K 0.03% 324
2022
Q3
$227K Buy
+3,409
New +$216K 0.02% 353

Other funds holding CAH

Equitable Trust's CAH Position: Q1 2026 in Review

Equitable Trust increased its Cardinal Health (CAH) stake by 35% in Q1 2026, buying an estimated $177K and bringing the position to 3,188 shares worth $674K. The position accounts for 0.03% of the portfolio, ranked #278.

Equitable Trust first reported a position in CAH in Q3 2022 and has held it in 15 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Equitable Trust held 3,188 shares of Cardinal Health worth $674K as of Q1 2026.
  • Equitable Trust bought 823 Cardinal Health shares in Q1 2026, an estimated $177K.
  • Cardinal Health made up 0.03% of Equitable Trust's portfolio in Q1 2026, its #278 holding.
  • Equitable Trust first reported a position in Cardinal Health in Q3 2022 and has held it in 15 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.